Carregant...
A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth
Prolactin secreting pituitary adenomas (prolactinomas) is the most common pituitary tumors in humans. Animal studies have identified aggressive prolactinoma development in fetal alcohol exposed rats. We have recently identified a combination treatment of a μ opioid receptor antagonist naltrexone and...
Guardat en:
| Publicat a: | J Cell Commun Signal |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Netherlands
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5559393/ https://ncbi.nlm.nih.gov/pubmed/28144772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-017-0374-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|